commercialisation

News: commercialisation

Adelaide bike technology’s role in world record attempt

Posted on Oct 6 2022 by Rebecca Jane Farrell

Technology developed and patented by ��˴�Ƭ researchers will power Olympic and world track cycling champion Filippo Ganna in his world record quest.

Trailblazing new opportunities to commercialise defence research

Posted on Feb 10 2022 by Rebecca Jane Farrell

A major defence research commercialisation project between the ��˴�Ƭ and the University of New South Wales is one of just eight proposals shortlisted for the Federal Government’s new $242.7 million Trailblazer Universities program.

Fortescue Future Industries, Sparc Technologies and the ��˴�Ƭ partner to tackle the future of clean energy

Posted on Feb 3 2022 by Rebecca Jane Farrell

Sparc Technologies Ltd (ASX: SPN) has entered into binding agreements with global green energy company Fortescue Future Industries Pty Ltd (an entity of Fortescue Metals Group Ltd ASX: FMG) and the ��˴�Ƭ, forming the Sparc Hydrogen Pty Ltd Joint Venture (Sparc Hydrogen).

Success for Adelaide-led medical research

Posted on Jul 1 2021 by Rebecca Jane Farrell

The ��˴�Ƭ has been awarded more than $8.8 million in research grants from the Federal Government’s Medical Research Future Fund’s (MRFF) to support targeted research on new ways to address risk factors for chronic and complex diseases.

Sparc Technologies granted patent for graphene based remediation technology

Posted on Jun 8 2021 by Rebecca Jane Farrell

Sparc Technologies Limited (ASX:SPN) is pleased to announce it has received confirmation that the United States (USA) patent application number 15/578149 has now been issued as a patent.

ALHI $28.9M MRFF Grant revolutionises lung function scanning

Posted on Mar 9 2021 by Rebecca Jane Farrell

The Australian Lung Health Initiative (ALHI) has been granted $28.9 million in funding from the Australian Federal Government's Medical Research Future Fund (MRFF) Frontier Health and Medical Research initiative, to be provided in tranches over the next five years, to achieve medical breakthroughs with the potential to impact on a global scale.

ONLINE WORKSHOP: Tips to translate your research

Posted on Oct 29 2020 by Rebecca Jane Farrell

One hour online workshops for ��˴�Ƭ's Life Sciences and Physical Sciences research staff led by ��˴�Ƭ investment partner, IP Group.

Describe your Advanced Materials, or Advanced/Additive Manufacturing research on a page for a chance at $10k

Posted on Oct 26 2020 by Rebecca Jane Farrell

Innovyz are seeking innovations in the areas of Advanced Materials, or Advanced/Additive Manufacturing. To encourage you to think about the commercial opportunities of your research, Innovyz are awarding prizes of $10k for first, $5k for second and $2.5k for third, based on the technical and commercial merit of your work, as evidenced by your poster. Deadline: Friday 19 February 2021.

$1.35M for world-first needle-free Zika virus vaccine

Posted on Sep 3 2020 by Rebecca Jane Farrell

Researchers at the ��˴�Ƭ have been awarded $1.35 million in funding to accelerate development of a world-first vaccine for the Zika virus.

VivaZome licenses ��˴�Ƭ stem cell technology

Posted on May 14 2020 by Rebecca Jane Farrell

VivaZome Therapeutics and the ��˴�Ƭ have entered into a series of agreements encompassing licensing of technology, access to stem cells and conduct of research, all in support of VivaZome’s mission to develop and commercialise exosome-based therapeutics.